France: Recent Developments in Pricing & Market Access

Published on February 13, 2024

Two new policies were implemented in France this year changing pricing and market access for pharmaceuticals. Experts Diane Cosset, Charles Hoffman-Martinot, and Igor Seban outline what this means for manufacturers.  

Healthcare is changing in France. In line with the country’s “Healthcare Innovation Plan 2030” two new policies have been announced which are changing pricing and market access. The first policy is a new decree that provides broader access to expensive drug coverage in hospitals. And the second is a new pricing policy for orphan drugs.  

In this brief, we outline the new policies and explain what effects they will have on France’s healthcare industry.     

france